COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    chadox1 | MERS (Middle East Respiratory Syndrome) | Saudi Arabia
Previous Study | Return to List | Next Study

A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04170829
Recruitment Status : Recruiting
First Posted : November 20, 2019
Last Update Posted : February 20, 2020
University of Oxford
Information provided by (Responsible Party):
King Abdullah International Medical Research Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 1, 2020
Estimated Study Completion Date : January 1, 2021